← Back to Search

Behavioral Intervention

Remote Multisensory Rehabilitation for Spinal Cord Injury

Phase 2

Recruiting

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial may provide a new therapy for chronic SCI that could improve function and neurological recovery, accessible to more patients.

Who is the study for?

This trial is for adults aged 18-75 with spinal cord injury or disease, stable in health, and at least 3 months post-injury. They must be able to follow directions and not have MRI contraindications, uncontrolled seizures, cognitive impairments preventing learning, ventilator dependency, other major medical issues or pregnancy.Check my eligibility

What is being tested?

The study tests remote cognitive multisensory rehabilitation (CMR) and exercise programs for improving sensory and motor functions in chronic spinal cord injury patients. It aims to demonstrate the effectiveness of CMR delivered remotely and its impact on brain function.See study design

What are the potential side effects?

Since this trial involves rehabilitation exercises rather than medication, side effects may include muscle soreness or fatigue from physical activity. There's also a potential risk of discomfort during sensory training.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Neurologic Exam

The SCI-FI/AT

the Neuromuscular Recovery Scale (NRS)

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Remote CMRExperimental Treatment1 Intervention

adults with SCI without restriction for race, sex or socio-economic status randomized to CMR intervention.

Group II: Remote exercisesPlacebo Group1 Intervention

adults with SCI without restriction for race, sex or socio-economic status randomized to remote exercise intervention.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,381 Previous Clinical Trials

1,588,953 Total Patients Enrolled

Media Library

Remote CMR (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05870189 — Phase 2

Spinal Cord Injury Research Study Groups: Remote CMR, Remote exercises

Spinal Cord Injury Clinical Trial 2023: Remote CMR Highlights & Side Effects. Trial Name: NCT05870189 — Phase 2

Remote CMR (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05870189 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the subject pool for this study composed of individuals aged twenty and over?

"Patients of legal age (18-75) are eligible to enroll in this trial. Additional studies for underage and elderly participants, respectively numbering 156 and 816, exist as well."

Answered by AI

Is enrollment for this medical trial available to new participants?

"Confirming the data found on clinicaltrials.gov, this experiment is not in search of applicants at present, despite having been published and updated as recently as June 1st 2023 and May 11th 2023 respectively. Though no longer recruiting patients, 1002 other trials are currently seeking volunteers."

Answered by AI

For whom is enrollment in this medical study appropriate?

"This research project is recruiting up to 22 participants who are afflicted with spinal cord injury and aged between 18 and 75 years old."

Answered by AI

Has the FDA officially sanctioned Remote CMR?

"Remote CMR is placed at a safety rating of 2, as the clinical trial currently underway is in Phase 2 and thus only data related to security has been gathered."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Remotely Delivered Cognitive Multisensory Rehabilitation for Sensory and Motor Recovery After Spinal Cord Injury

2023. "Remotely Delivered Cognitive Multisensory Rehabilitation for Sensory and Motor Recovery After Spinal Cord Injury". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05870189.

All > Cervical Spondylotic Myelopathy